JB Hi-Fi Shares Flat as Profit and Sales Rise
Retailer JB Hi-Fi [ASX:JBH] released its full-year results today, announcing NPAT for the year rose 7.7% to $545 million in FY22.
Retailer JB Hi-Fi [ASX:JBH] released its full-year results today, announcing NPAT for the year rose 7.7% to $545 million in FY22.
Oil and gas producer Beach Energy [ASX:BPT] fell more than 12% on Monday after FY22 production disappointed.
Shares of aerial imagery and location data company Nearmap [ASX:NEA] surged on Monday to their highest level since November last year after a non-binding takeover offer for $2.10 cash per share.
Magnis Energy Technologies [ASX:MNS] announced today that commercial production has started at the Imperium3 New York (iM3NY) lithium-ion battery manufacturing plant. Magnis, with its joint venture partner Charge CCCV [C4V], are the major shareholders in iM3NY. iM3NY expects first sales in late September with the preceding weeks used for quality assurance. MNS shares rose as […]
The upcoming series features industry voices with years of experience, insight, and expertise. Hosted by our gold stock investing expert Brian Chu, the series will feature industry veterans Peter Schiff, Don Durrett, Bill Bonner, and Jim Rickards.
Telecom giant Telstra [ASX:TLS] released its FY22 results today, reporting a dip in total income, NPAT, and EBITDA for the 2022 financial year but a higher dividend.
Lotus Resources [ASX:LOT] released its DFS, ‘confirming Kayelekera as a low-cost, quick restart uranium operation.’
Freelancer [ASX:FLN] announced a merger of its freight divisions to form what it called ‘Australia’s largest freight marketplace’.
Agriculture company GrainCorp [ASX:GNC] upgraded its earnings guidance on Wednesday. As a result, GrainCorp’s shares spiked over 5%. Year-to-date, however, GNC shares have been flat. GrainCorp, after hitting a 52-week high of $10.86 in May, is currently trading at around $8 a share: Source: www.tradingview.com GrainCorp’s FY22 earnings upgrade GrainCorp has upgraded its earnings guidance […]
Biotech immunotherapy company Imugene [ASX:IMU] rose more than 10% on Wednesday after releasing an update about its oncolytic virotherapy candidate.
Investment ideas from the edge of the bell curve.
Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.
All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.
The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988